GO:1903593 regulation of histamine secretion by mast cell: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903593 describes any process that modulates the frequency, rate or extent of histamine secretion by mast cells, a key event in allergy, itch, and neuroimmune signaling [1, 8].
• Mast cell histamine release is regulated by IgE-dependent and IgE-independent pathways, including MRGPRX2 and G-protein coupled receptor activation [6, 8].
• Cyclic AMP and adenylate cyclase activity are central intracellular regulators of mast cell activation and secretion.
• The mast cell clock and stress modulate plasma histamine levels, linking circadian biology to histamine regulation.
• Mast cells regulate the brain-dura interface and CSF dynamics, expanding the physiological importance of histamine secretion beyond allergy.
• Human skin mast cell histamine release is modulated by PDE inhibitors, highlighting phosphodiesterase as a regulatory node.
Description
Regulation of histamine secretion by mast cell (GO:1903593) is a biological process that encompasses any mechanism controlling the frequency, rate, or extent of histamine release from mast cells [1, 8]. Histamine is a biogenic amine stored in mast cell granules and released upon activation, and its secretion is tightly controlled to prevent excessive inflammation and tissue damage. This GO term is critical for researchers studying allergy, itch, neuroimmune interactions, and cardiovascular homeostasis, as dysregulated histamine secretion contributes to multiple pathologies [1, 4, 8]. The process integrates signals from IgE receptors, G-protein coupled receptors such as MRGPRX2, and intracellular second messengers like cyclic AMP [3, 6, 8]. Recent studies have also revealed that mast cells regulate the brain-dura interface and cerebrospinal fluid dynamics, underscoring the broad physiological relevance of regulated histamine secretion. Understanding GO:1903593 therefore provides a framework for dissecting molecular checkpoints that can be targeted in mast cell-driven diseases.
regulation of histamine secretion by mast cell At A Glance
| GO ID | GO:1903593 |
|---|---|
| GO term | regulation of histamine secretion by mast cell |
| Ontology | biological_process |
| Synonym | none |
| Major function | Modulates the frequency, rate, or extent of histamine release from mast cells |
| Related cell type | Mast cells |
| Key regulators | IgE, MRGPRX2, cyclic AMP, adenylate cyclase, phosphodiesterases, mast cell clock |
| Physiological contexts | Allergy, itch, neuroimmune signaling, cardiovascular homeostasis, CSF dynamics |
What Is GO:1903593?
GO:1903593 is defined as any process that modulates the frequency, rate or extent of histamine secretion by mast cell. In other words, it covers all regulatory inputs, signaling cascades, and feedback mechanisms that determine how much histamine a mast cell releases and how often, without directly describing the secretory machinery itself.
Why Is regulation of histamine secretion by mast cell Important in Cell Biology?
GO:1903593 is important because histamine is a potent mediator of immediate hypersensitivity, itch, and vascular permeability, and its release must be tightly regulated to avoid chronic inflammation and tissue injury [1, 4, 8]. Dysregulation of this process is implicated in allergic disorders, skin diseases, and neuroimmune conditions, making it a target for therapeutic intervention [1, 5, 6]. Moreover, recent evidence shows that mast cells regulate the brain-dura interface and CSF dynamics, suggesting that regulated histamine secretion influences central nervous system physiology.
• Allergic reactions: IgE-mediated mast cell degranulation is a core mechanism of type I hypersensitivity.
• Itch and neuroimmune crosstalk: basophil-neuronal axis and mast cell histamine contribute to itch.
• Skin disorders: human skin mast cell histamine release is modulated by PDE inhibitors, relevant to urticaria and dermatitis.
• Drug-induced pseudoallergy: MRGPRX2 mediates degranulation triggered by pethidine and fentanyl.
• Cardiovascular regulation: histamine regulates the cardiovascular system.
• Circadian and stress responses: the mast cell clock and stress modulate plasma histamine levels.
• CSF dynamics and brain-dura interface: mast cells regulate these processes.
• Therapeutic targeting: cyclic AMP-dependent pathways are druggable regulators of mast cell secretion.
• Mast cell maturation: IgE and histamine influence mast cell maturation.
• Research models: LAD2 cells and human skin mast cells are used to study regulation of histamine release [5, 6].
What Happens During regulation of histamine secretion by mast cell?
Initiation by IgE and MRGPRX2
In simple terms: Mast cells can be triggered to release histamine by antibodies or by certain drugs and peptides.
Histamine secretion is initiated when allergens crosslink IgE bound to FcεRI, or when ligands such as pethidine and fentanyl activate MRGPRX2 [6, 8]. These receptors trigger intracellular signaling that leads to degranulation. IgE-mediated activation is a classic pathway, while MRGPRX2 provides an IgE-independent route for drug-induced pseudoallergy [6, 8].
Cyclic AMP and adenylate cyclase modulation
In simple terms: A molecule called cyclic AMP acts like a brake or accelerator for histamine release.
Adenylate cyclase and cyclic AMP-dependent protein kinases regulate mast cell activation and secretion. Elevation of cyclic AMP generally inhibits degranulation, and phosphodiesterase inhibitors that increase cyclic AMP reduce human skin mast cell histamine release. Thus, the cyclic AMP pathway is a central intracellular checkpoint in GO:1903593 [3, 5].
Circadian and stress regulation
In simple terms: The body clock and stress can change how much histamine is in the blood.
The mast cell clock regulates plasma histamine levels, and stress modulates this clock to alter histamine secretion. This indicates that GO:1903593 is subject to systemic timing cues, linking circadian biology to mast cell function.
Mast cell maturation and histamine content
In simple terms: How mature a mast cell is affects how much histamine it can release.
IgE and histamine play roles in mast cell maturation, influencing the cell's capacity for histamine secretion. Therefore, regulation of histamine secretion includes developmental and maturation-dependent components.
Neuroimmune and brain-dura interactions
In simple terms: Mast cells talk to nerves and the brain's covering, affecting fluid movement.
Mast cells regulate the brain-dura interface and CSF dynamics, and a basophil-neuronal axis promotes itch [1, 2]. These findings expand the physiological contexts in which regulated histamine secretion operates beyond classical allergy [1, 2].
Key Genes Involved in GO:1903593 regulation of histamine secretion by mast cell
The following genes and proteins are experimentally implicated in the regulation of histamine secretion by mast cells.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FcεRI | High-affinity IgE receptor; triggers degranulation upon allergen crosslinking | Central to IgE-mediated histamine release |
| MRGPRX2 | G-protein coupled receptor activated by drugs like pethidine and fentanyl | Mediates IgE-independent mast cell degranulation |
| ADCY (adenylate cyclase) | Enzyme that produces cyclic AMP | Regulates mast cell activation and secretion |
| PKA (cyclic AMP-dependent protein kinase) | Effector of cyclic AMP signaling | Modulates mast cell secretion |
| PDE (phosphodiesterase) | Degrades cyclic AMP | Inhibitors reduce human skin mast cell histamine release |
| Clock genes | Regulate circadian rhythms in mast cells | Modulate plasma histamine levels and stress responses |
| IgE | Antibody that binds FcεRI | Involved in mast cell maturation and activation |
| Histamine | Biogenic amine stored in granules | End product whose secretion is regulated |
| LAD2 cell markers | Human mast cell line characteristics | Used to study MRGPRX2-mediated degranulation |
| Skin mast cell markers | Human skin mast cell phenotype | Used to study PDE inhibitor effects |
| Basophil markers | Related granulocyte population | Implicated in itch via neuronal axis |
| Dural mast cell markers | Mast cells at brain-dura interface | Regulate CSF dynamics |
| Cardiovascular histamine receptors | H1 and H2 receptors | Mediate cardiovascular effects of histamine |
| Stress mediators | Hormones and neurotransmitters | Modulate mast cell clock and histamine release |
| FcεRI signaling kinases | Downstream kinases like Syk | Potential targets for regulating secretion |
| Calcium channels | Mediate calcium influx required for degranulation | Essential for histamine release |
| G-proteins | Transduce MRGPRX2 signals | Involved in IgE-independent activation |
How Is regulation of histamine secretion by mast cell Regulated?
Regulation of histamine secretion by mast cells is controlled by multiple intracellular and extracellular inputs. Cyclic AMP acts as a key inhibitory second messenger, and phosphodiesterase inhibitors that elevate cyclic AMP reduce histamine release from human skin mast cells. Adenylate cyclase and cyclic AMP-dependent protein kinases are direct enzymatic regulators of mast cell activation and secretion. The mast cell clock and stress responses further modulate plasma histamine levels, indicating circadian control. IgE and histamine themselves influence mast cell maturation, creating feedback loops. Additionally, MRGPRX2 provides an IgE-independent activation route that can be targeted to modulate secretion.
regulation of histamine secretion by mast cell and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MRGPRX2 | Drug-induced pseudoallergy | LAD2 cells with MRGPRX2 knockout |
| FcεRI | Allergic rhinitis, asthma | Human mast cell lines with FcεRI knockdown |
| PDE | Skin mast cell disorders | Human skin mast cells treated with PDE inhibitors |
| Clock genes | Stress-related histamine fluctuations | Mast cell clock gene knockout mice |
| Dural mast cells | CSF dynamics and neuroinflammation | Mast cell-deficient mouse models |
Allergic and Itch Disorders
Dysregulated histamine secretion from mast cells is a hallmark of allergic reactions and chronic itch. A basophil-neuronal axis promotes itch, and mast cell histamine is a key mediator. IgE-mediated activation and MRGPRX2-dependent pathways contribute to pseudoallergic reactions to drugs like pethidine and fentanyl [6, 8]. Targeting the regulation of histamine secretion could therefore alleviate itch and allergic symptoms [1, 6].
Skin Mast Cell Disorders
Human skin mast cells release histamine in response to various stimuli, and PDE inhibitors modulate this release. This has implications for urticaria, atopic dermatitis, and other skin conditions where histamine drives inflammation and pruritus.
Neuroimmune and CSF Dynamics
Mast cells regulate the brain-dura interface and CSF dynamics, linking histamine secretion to central nervous system physiology. Disruption of this regulation may contribute to neuroinflammatory conditions, although further research is needed.
Cardiovascular Implications
Histamine regulates the cardiovascular system, and excessive mast cell histamine release can cause vasodilation, hypotension, and tachycardia. Understanding GO:1903593 may inform therapies for histamine-mediated cardiovascular events.
From regulation of histamine secretion by mast cell-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does MRGPRX2 mediate drug-induced histamine release? | MRGPRX2 knockout LAD2 cells |
| Does cyclic AMP elevation inhibit histamine secretion? | PDE inhibitor treatment in human skin mast cells |
| Does the mast cell clock regulate plasma histamine? | Clock gene knockout mice |
| Does IgE affect mast cell maturation and histamine content? | IgE knockout or transgenic mice |
| Do dural mast cells regulate CSF dynamics? | Mast cell-deficient mouse models |
| Does histamine contribute to itch? | Basophil-neuronal axis models |
How to Study the regulation of histamine secretion by mast cell Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Histamine ELISA | Histamine concentration in supernatants | Quantify mast cell degranulation |
| Cyclic AMP assay | Intracellular cyclic AMP levels | Assess adenylate cyclase/PDE activity |
| CRISPR knockout | Gene function loss | Test MRGPRX2 role in degranulation |
| RNA-seq | Transcriptomic changes | Identify regulators of histamine secretion |
| Western blot | Protein expression and phosphorylation | Measure signaling pathway activation |
| Calcium imaging | Intracellular calcium flux | Monitor early degranulation events |
| Circadian monitoring | Plasma histamine over time | Study mast cell clock regulation |
| Flow cytometry | Mast cell surface markers | Assess maturation and activation |
Measuring Histamine Release
Histamine secretion is typically quantified using enzyme-linked immunosorbent assays or fluorometric assays on mast cell supernatants after stimulation. These methods are used to assess the effects of regulators such as PDE inhibitors or MRGPRX2 agonists [5, 6].
Cyclic AMP Quantification
Cyclic AMP levels can be measured using competitive immunoassays or biosensors to determine the impact of adenylate cyclase and phosphodiesterase activity on mast cell secretion [3, 5].
Genetic Knockout and Knockdown
CRISPR-Cas9 or RNA interference can be used to knock out or knockdown candidate genes such as MRGPRX2 or FcεRI signaling components in mast cell lines like LAD2, followed by histamine release assays [6, 8].
Circadian and Stress Studies
Plasma histamine levels can be measured over a 24-hour cycle in animal models to assess the role of the mast cell clock and stress.
How CRISPR Can Be Used to Study GO:1903593 regulation of histamine secretion by mast cell
Knockout
CRISPR knockout of MRGPRX2 in LAD2 cells can confirm its role in drug-induced histamine release, as demonstrated by reduced degranulation upon pethidine or fentanyl treatment. Similarly, knocking out FcεRI signaling components can abolish IgE-mediated histamine secretion.
Point Mutation
Point mutations in MRGPRX2 or FcεRI subunits can be introduced to dissect specific residues required for ligand binding or signal transduction, providing mechanistic insights into regulation of histamine secretion [6, 8].
Knock-in
Knock-in of tagged versions of key regulators, such as cyclic AMP-dependent protein kinase, can enable live-cell imaging of their dynamics during mast cell activation.
Overexpression
Overexpression of phosphodiesterases or adenylate cyclase in mast cell lines can test whether increasing cyclic AMP degradation or synthesis alters histamine secretion, validating their regulatory roles [3, 5].
How EDITGENE Supports regulation of histamine secretion by mast cell Research
Researchers studying regulation of histamine secretion by mast cell-related genes often need to determine whether a candidate gene is causally involved in modulating histamine release, and CRISPR-based models provide a direct way to test this.
Contact EDITGENE today to design your custom CRISPR model for regulation of histamine secretion by mast cell research.
Frequently Asked Questions About regulation of histamine secretion by mast cell
What is GO:1903593?
GO:1903593 is a Gene Ontology biological process term defined as any process that modulates the frequency, rate or extent of histamine secretion by mast cell.
What genes are involved in regulation of histamine secretion by mast cell?
Key genes include MRGPRX2, FcεRI, adenylate cyclase, cyclic AMP-dependent protein kinases, phosphodiesterases, and clock genes [3, 5, 6, 7, 8].
How is histamine secretion regulated in mast cells?
It is regulated by IgE-dependent and IgE-independent pathways, cyclic AMP signaling, phosphodiesterases, the mast cell clock, and stress responses [3, 5, 6, 7, 8].
What is the role of MRGPRX2 in histamine secretion?
MRGPRX2 mediates IgE-independent mast cell degranulation triggered by drugs like pethidine and fentanyl.
How does cyclic AMP affect mast cell histamine release?
Cyclic AMP generally inhibits mast cell activation and secretion; adenylate cyclase and cyclic AMP-dependent protein kinases regulate this process.
Do PDE inhibitors affect histamine release?
Yes, PDE inhibitors that elevate cyclic AMP reduce human skin mast cell histamine release.
What is the mast cell clock?
The mast cell clock regulates plasma histamine levels and is modulated by stress.
How can I study regulation of histamine secretion by mast cell?
You can use histamine ELISA, cyclic AMP assays, CRISPR knockout, RNA-seq, and circadian monitoring in mast cell models [3, 5, 6, 7, 8].
What diseases are linked to dysregulated histamine secretion?
Allergic disorders, itch, skin mast cell disorders, and neuroimmune conditions [1, 2, 4, 5, 6, 8].
Does EDITGENE provide CRISPR services for mast cell research?
Yes, EDITGENE offers knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services for mast cell research.
Conclusion
GO:1903593 regulation of histamine secretion by mast cell is a critical biological process that integrates IgE-dependent and IgE-independent signals, cyclic AMP signaling, circadian cues, and neuroimmune interactions [1, 2, 3, 5, 6, 7, 8]. Understanding its molecular regulators offers therapeutic opportunities for allergy, itch, and neuroinflammatory diseases [1, 4, 5, 6, 8]. CRISPR-based models and EDITGENE services can accelerate research into this process.
References
- 1. Wang F et al.. 2021. A basophil-neuronal axis promotes itch.. Cell 184(2):422-440.e17 PMID: 33450207
- 2. Mamuladze T et al.. 2025. Mast cells regulate the brain-dura interface and CSF dynamics.. Cell 188(20):5487-5498.e16 PMID: 40712577
- 3. Winslow CM et al.. 1982. Enzymatic regulation of mast cell activation and secretion by adenylate cyclase and cyclic AMP-dependent protein kinases.. Fed Proc 41(1):22-9 PMID: 6173264
- 4. Hattori Y et al.. 2017. Regulation of the Cardiovascular System by Histamine.. Handb Exp Pharmacol 241:239-258 PMID: 27838850
- 5. Eskandari N et al.. 2015. Regulation of human skin mast cell histamine release by PDE inhibitors.. Allergol Immunopathol (Madr) 43(1):37-41 PMID: 24231152
- 6. Liu R et al.. 2018. Relationship between MRGPRX2 and pethidine hydrochloride- or fentanyl citrate-induced LAD2 cell degranulation.. J Pharm Pharmacol 70(12):1596-1605 PMID: 30256417
- 7. Nakamura Y et al.. 2017. Regulation of plasma histamine levels by the mast cell clock and its modulation by stress.. Sci Rep 7:39934 PMID: 28074918
- 8. Tanaka S et al.. 2021. Roles of IgE and Histamine in Mast Cell Maturation.. Cells 10(8) PMID: 34440939
